| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 138.040 | 156.690 | 222.304 | 352.459 | 416.075 | 545.122 | 610.826 | 726.040 | 859.837 | 994.524 |
| Total Income - EUR | 138.040 | 156.648 | 222.304 | 352.459 | 416.077 | 545.126 | 610.830 | 726.044 | 860.047 | 994.691 |
| Total Expenses - EUR | 110.730 | 133.885 | 208.966 | 325.598 | 386.278 | 493.146 | 547.353 | 678.785 | 775.645 | 944.509 |
| Gross Profit/Loss - EUR | 27.310 | 22.763 | 13.338 | 26.862 | 29.799 | 51.979 | 63.478 | 47.259 | 84.402 | 50.182 |
| Net Profit/Loss - EUR | 23.186 | 19.121 | 10.823 | 23.290 | 25.619 | 46.790 | 57.488 | 40.847 | 72.890 | 38.992 |
| Employees | 0 | 3 | 4 | 7 | 7 | 8 | 8 | 9 | 9 | 10 |
Check the financial reports for the company - Farmacia Pharma Byamar Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 34.053 | 24.783 | 15.825 | 7.208 | 272 | 927 | 611 | 747 |
| Current Assets | 67.593 | 82.696 | 126.645 | 163.360 | 226.249 | 307.556 | 245.991 | 271.734 | 328.036 | 384.001 |
| Inventories | 36.046 | 54.040 | 79.582 | 84.298 | 109.363 | 124.431 | 132.523 | 127.895 | 153.547 | 150.668 |
| Receivables | 21.300 | 9.905 | 45.224 | 59.994 | 50.188 | 81.941 | 93.220 | 122.446 | 145.764 | 147.865 |
| Cash | 10.247 | 18.750 | 1.839 | 19.068 | 66.699 | 101.185 | 20.249 | 21.393 | 28.725 | 85.468 |
| Shareholders Funds | 28.766 | 47.594 | 57.611 | 79.844 | 103.917 | 148.737 | 62.274 | 62.759 | 84.918 | 43.022 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 38.827 | 35.102 | 105.272 | 109.285 | 138.158 | 166.028 | 183.989 | 209.902 | 243.730 | 341.726 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Farmacia Pharma Byamar Srl